147 211

Cited 0 times in

눈부심측정기를 이용한 눈부심의 정량적 측정

Other Titles
 Quantitative Measurement of Glare Disability Using a Glaremeter. 
 송유경  ;  최철명  ;  김성수  ;  이형근 
 Journal of the Korean Ophthalmological Society (대한안과학회지), Vol.53(7) : 953-959, 2012 
Journal Title
 Journal of the Korean Ophthalmological Society  (대한안과학회지) 
Issue Date
PURPOSE: To report glare disability measured by a glaremeter. METHODS: Glaremeter values were measured in 270 normal eyes and 100 pseudophakic eyes. The normal eyes were classified into 3 age groups (teenage to 60's) with 90 eyes in each group. The pseudophakic eyes were classified into the monofocal IOL (intraocular lens) and multifocal IOL implanted groups with 50 eyes in each group. Glaremeter values of each group were measured using a glaremeter under photopic (82.2 +/- 5.1 cd/m2) and mesopic (5.5 +/- 0.3 cd/m2) conditions. RESULTS: The highest mean glaremeter value in the normal eyes was 8657.34 +/- 691.04 mm2 under the photopic condition and 8837.97 +/- 805.83 mm2 under the mesopic condition in the oldest group. The glaremeter value of the multifocal IOL implanted group was 9390.87 +/- 846.7 mm2 under the photopic condition and 9799.87 +/- 823.72 mm2 under the mesopic condition, which was significantly higher than the normal eye and the monofocal IOL implanted groups (p < 0.05). CONCLUSIONS: In the normal population, the mean glaremeter values were increased according to age, and a significant increase was observed in the multifocal IOL implanted group. The present study results provide good basic data for cataract and presbyopia refractive surgery predicted to produce glare disability inevitably.
Files in This Item:
T201203627.pdf Download
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실)
Yonsei Authors
김성수(Kim, Sung Soo) ORCID logo https://orcid.org/0000-0002-0574-7993
이형근(Lee, Hyung Keun) ORCID logo https://orcid.org/0000-0002-1123-2136
RIS (EndNote)
XLS (Excel)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.